Company intelligence / Profile preview

Alimentiv

Ownership: Private
Employees: ~320
Development stage: Commercial

Overview

Alimentiv (formerly Robarts Clinical Trials) specializes in global gastrointestinal clinical research. It has established itself as an industry leader in the design and execution of studies in inflammatory bowel disease and related GI conditions. The company collaborates with major pharmaceutical companies worldwide and academic institutions to deliver innovative trial designs, central imaging solutions, and precision medicine approaches.

Therapeutic areas: Gastroenterology
Industry: Contract Research Organization

Partnerships

Collaborates with six of the world’s ten largest pharmaceutical companies; works with over 1,200 hospitals/clinics globally. Specific partners are confidential.

Beyond the preview

Go deeper on Alimentiv.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Alimentiv.

Explore the full profile